Skip to content

Polycystic Kidney Disease 9 Susceptibility To C6012712

Published: July 22, 2026Updated: August 20, 2026

A genetic predisposition to develop fluid-filled kidney cysts that may affect kidney function over time. It runs in families and requires monitoring. Treatment focuses on managing symptoms and complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Changes in urination or swelling

(renal)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Hypertension

(renal)

Flank pain

(renal)

Hematuria

(renal)

Chronic kidney disease

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Regular Renal Imaging Surveillance

Periodic abdominal ultrasound and MRI monitoring to assess cyst burden, kidney size, and progression of polycystic kidney disease. Early detection of complications allows for timely intervention.

monitoring
3

Blood Pressure Management

Pharmacologic control of hypertension using ACE inhibitors or angiotensin receptor blockers as first-line agents to reduce cardiovascular risk and slow disease progression. Blood pressure targets should be individualized.

medication

Additional treatment options

Sodium and Protein Intake Modification

Dietary counseling to reduce sodium intake below 2,300mg daily and moderate protein consumption to help manage blood pressure and reduce kidney workload. Adequate hydration is also recommended.

dietary

Genetic Counseling

Family history assessment and genetic counseling services to discuss inheritance patterns, family screening recommendations, and reproductive planning options. Autosomal dominant PKD has 50% transmission risk.

complementary

Cardiovascular Risk Reduction

Implementation of heart-healthy lifestyle modifications including regular physical activity, smoking cessation, weight management, and avoidance of nephrotoxic substances. Cardiovascular complications are major concerns in PKD.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Polycystic Kidney Disease 9 Susceptibility To C6012712?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harris PC, Torres VE, Watnick TJ. KDIGO Clinical Practice Guideline for Polycystic Kidney Disease. Kidney Int Suppl. 2020.

guideline2020
2

Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019.

review2019
3

Iglesias CG, Torres VE, Offermann JR, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012.

clinical_trial2012
4

Savige J, Mallett A, Hughes P, et al. Clinical practice guidelines for the management of polycystic kidney disease. Nephrology. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Polycystic Kidney Disease 9 Susceptibility To C6012712. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy